军事知识服务平台
Protein arginine methyltransferase 5 as a novel therapeutic target in solid tumors
摘要 Protein arginine methyltransferase 5(PRMT5)is the primary type Ⅱ methyltransfer-ase that mainly catalyzes symmetric demethylation of arginine residues in both histone and nonhistone proteins.Increasing evidence has demonstrated that PRMT5 is indispensable in tumorigenesis and acquired therapeutic resistance in multiple malignancies.This review sum-marizes the clinical significance of PRMT5 in solid tumors such as lung cancer,breast cancer,and glioblastoma,its role in tumor immunology,and current clinical trials of PRMT5 inhibitors,and discusses the clinical status,current dilemma,and future perspectives of PRMT5 inhibition as a novel therapeutic strategy.
刊 名 基因与疾病(英文) ISTICSCI
年,卷(期): 2026, 13(1)
机标分类号: TP311 S H13
在线出版日期: 2026年4月21日